Cyrus Harmon, Director at Olema Pharmaceuticals, Inc. (OLMA), sold 10,000 shares at $6.05 ($62K) on 2023-06-05, disclosed to the SEC on 2023-06-07.
Open-market sale of $62k OLMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.05 | 5,000 | $30K | 49.0% |
| 2 | $6.30 | 5,000 | $32K | 51.0% |
| Total | $6.17 avg | 10,000 | $62K | 100% |
| Filing → |
| OLMA | SELL | 2026-01-16 | $102K | — | Filing → |
| OLMA | SELL | 2025-12-29 | $164K | — | Filing → |
| OLMA | SELL | 2025-09-18 | $285K | — | Filing → |